Page last updated: 2024-09-04

fidarestat and Pain

fidarestat has been researched along with Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hotta, N; Ishii, J; Kaneko, T; Kikkawa, R; Koike, Y; Matsuoka, K; Sakamoto, N; Shigeta, Y; Sugimura, K; Takahashi, A; Toyota, T	1

Trials

1 trial(s) available for fidarestat and Pain

Article	Year
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes care, 2001, Volume: 24, Issue:10 Topics: Aldehyde Reductase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electrophysiology; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Hypesthesia; Imidazoles; Imidazolidines; Male; Middle Aged; Pain; Paresthesia; Placebos	2001

Article

Year

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

Diabetes care, 2001, Volume: 24, Issue:10

Topics: Aldehyde Reductase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electrophysiology; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Hypesthesia; Imidazoles; Imidazolidines; Male; Middle Aged; Pain; Paresthesia; Placebos

2001